SEMANEO 0.5mg Injection Pen

AboutSEMANEO 0.5mg Injection Pen contains Semaglutide 0.5mg dose, a GLP-1 receptor agonist for improved glycemic control and weight management.Usage Instructions: Inject subcutaneously once weekly. Rotate injection sites. Follow pen device instructions. Can be taken with or without food.Benefits: Superior blood sugar control, significant weight reduction, cardiovascular protection, once-weekly dosing convenience.How it Works: Activates GLP-1 receptors, enhancing glucose-dependent insulin secretion, inhibiting glucagon, slowing gastric emptying, promoting satiety.Side Effects: Nausea, diarrhea, vomiting, constipation, abdominal pain, reduced appetite, fatigue, injection site reactions.Safety Advice: Contraindicated in personal/family history of medullary thyroid carcinoma or MEN 2. Monitor for pancreatitis. Use caution in renal impairment. Discontinue if severe hypersensitivity occurs.Storage: Refrigerate at 2-8°C before first use. After initiation, may store at room temperature (up to 30°C) for up to 6 weeks. Do not freeze. Protect from light.